Pharmabiz

Karnataka govt appoints UT Khader as health minister

Our Bureau, Bengaluru Friday, June 5, 2026, 11:30 Hrs [IST] Karnataka government has now appointed U T Khader as health and f ...
Pharmabiz

Waters gets FDA 510(k) nod for BD BACTEC FXI Culture System, enabling broader access to bloodstream infection diagnostics

Waters gets FDA 510(k) nod for BD BACTEC FXI Culture System, enabling broader access to bloodstream infection diagnostics: ...
Pharmabiz

CDSCO directs all stakeholders to ensure establishment of pharmacovigilance system

CDSCO directs all stakeholders to ensure establishment of pharmacovigilance system: Gireesh Babu, New Delhi Friday, June 5, ...
Pharmabiz

Lupeng Pharma’s fourth-generation BTK inhibitor rocbrutinib approved in China for relapsed or refractory mantle cell lymphoma

Lupeng Pharma’s fourth-generation BTK inhibitor rocbrutinib approved in China for relapsed or refractory mantle cell lymphoma: Guangzhou, China Friday, June 5, 2026, 16:00 Hrs [ ...
Pharmabiz

Sanofi announces global employee shareholder plan to open on June 9

Sanofi announces global employee shareholder plan to open on June 9: Paris Friday, June 5, 2026, 18:00 Hrs [IST] Sanofi announced that its global employee shareholder plan, Action ...
Pharmabiz

Metropolis Healthcare recognised building a culture of quality and scientific excellence

Metropolis Healthcare recognised building a culture of quality and scientific excellence: Our Bureau, Bengaluru Friday, June 5, 2026, 16:20 Hrs [IST] Metropolis Healthcare has bee ...
Pharmabiz

Agilent, OpenAI & BCG collaborate to accelerate customer-focused, AI-driven scientific innovation

Agilent, OpenAI & BCG collaborate to accelerate customer-focused, AI-driven scientific innovation: Santa Clara, California Friday, June 5, 2026, 17:00 Hrs [IST] Agilent Technologi ...
Pharmabiz

UK MHRA grants marketing approval to Madrigal Pharmaceuticals’ resmetirom to treat metabolic dysfunction-associated steatohepatitis in adults

UK MHRA grants marketing approval to Madrigal Pharmaceuticals’ resmetirom to treat metabolic dysfunction-associated steatohepatitis in adults: United Kingdom Friday, June 5, 202 ...
Pharmabiz

US FDA grants orphan drug designation to Attralus Therapeutic’s zamubafusp alfa for the treatment of AL amyloidosis

US FDA grants orphan drug designation to Attralus Therapeutic’s zamubafusp alfa for the treatment of AL amyloidosis: Naples, Florida Friday, June 5, 2026, 14:00 Hrs [IST] Attral ...
Pharmabiz

Alembic Pharma receives US FDA final approval for haloperidol tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg & 20 mg

Alembic Pharma receives US FDA final approval for haloperidol tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg & 20 mg: Our Bureau, Mumbai Friday, June 5, 2026, 14:15 Hrs [IST] Alembic Pharm ...
Pharmabiz

US FDA approves expanded use of Agilent’s PD-L1 IHC 22C3 pharmDx on Dako Omnis in ESCC, TNBC, and gastric or gastroesophageal junction adenocarcinoma

US FDA approves expanded use of Agilent’s PD-L1 IHC 22C3 pharmDx on Dako Omnis in ESCC, TNBC, and gastric or gastroesophageal junction adenocarcinoma: Santa Clara, California Fr ...
Pharmabiz

Glenmark Pharma launches lacosamide injection USP, 200 mg/20 mL (10 mg/mL), single-dose vials

Glenmark Pharma launches lacosamide injection USP, 200 mg/20 mL (10 mg/mL), single-dose vials: Our Bureau, Mumbai Friday, June 5, 2026, 14:30 Hrs [IST] Glenmark Pharmaceuticals In ...